Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains.
The apical sorting of human intestinal dipeptidyl peptidase IV (DPPIV) occurs through complex N-linked and O-linked carbohydrates. Inhibition of O-linked glycosylation by benzyl-N-acetyl-alpha-d-galactosaminide affects significantly the sorting behavior of DPPIV in intestinal Caco-2 and HT-29 cells. However, random delivery to the apical and basolateral membranes and hence a more drastic effect on the sorting of DPPIV in both cell types is only observed when, in addition to O-glycans, the processing of N-glycans is affected by swainsonine, an inhibitor of mannosidase II. Together the data indicate that both types of glycosylation are critical components of the apical sorting signal of DPPIV. The sorting mechanism of DPPIV implicates its association with detergent-insoluble membrane microdomains containing cholesterol and sphingolipids, whereas an efficient association largely depends on the presence of a fully complex N- and O-linked glycosylated DPPIV. Interestingly, cholesterol is a more critical component in this context than sphingolipids, because cholesterol depletion by beta-cyclodextrin affects the detergent solubility and the sorting behavior of DPPIV more strongly than fumonisin, an inhibitor of sphingolipid synthesis.
Alfalah
Marwan
M
Department of Physiological Chemistry, School of Veterinary Medicine Hannover, Hannover D-30559, Germany.
Jacob
Ralf
R
Naim
Hassan Y
HY
D000116:Acetylgalactosamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D018938:Caco-2 Cells; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D003505:Cyclodextrins / Q000378:metabolism; D003902:Detergents / Q000494:pharmacology; D018819:Dipeptidyl Peptidase 4 / Q000737:chemistry* / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006026:Glycoside Hydrolases / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D007422:Intestines / Q000201:enzymology*; D008361:Mannosidases / Q000494:pharmacology; D021962:Membrane Microdomains / Q000737:chemistry / Q000378:metabolism*; D017830:Octoxynol / Q000494:pharmacology; D011134:Polysaccharides / Q000737:chemistry*; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D012697:Serine Endopeptidases / Q000378:metabolism; D017026:Swainsonine / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D001593:Benzyl Compounds; D003505:Cyclodextrins; D003902:Detergents; D004791:Enzyme Inhibitors; D011134:Polysaccharides; C080739:benzyl-alpha-N-acetylgalactosamine; D017830:Octoxynol; D002784:Cholesterol; D006026:Glycoside Hydrolases; D008361:Mannosidases; C038829:mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidase; D018819:Dipeptidyl Peptidase 4; D012697:Serine Endopeptidases; C028344:glutamyl endopeptidase; D014357:Trypsin; D000116:Acetylgalactosamine; D017026:Swainsonine